CN101965913A - Production method for tasteless enteric enrofloxacin microcapsules - Google Patents

Production method for tasteless enteric enrofloxacin microcapsules Download PDF

Info

Publication number
CN101965913A
CN101965913A CN2010105125310A CN201010512531A CN101965913A CN 101965913 A CN101965913 A CN 101965913A CN 2010105125310 A CN2010105125310 A CN 2010105125310A CN 201010512531 A CN201010512531 A CN 201010512531A CN 101965913 A CN101965913 A CN 101965913A
Authority
CN
China
Prior art keywords
enrofloxacin
stearic acid
production method
enteric
tasteless
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105125310A
Other languages
Chinese (zh)
Inventor
周玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WUXI ZHENGDA POULTRY CO Ltd
Original Assignee
WUXI ZHENGDA POULTRY CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WUXI ZHENGDA POULTRY CO Ltd filed Critical WUXI ZHENGDA POULTRY CO Ltd
Priority to CN2010105125310A priority Critical patent/CN101965913A/en
Publication of CN101965913A publication Critical patent/CN101965913A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a production method for tasteless enteric enrofloxacin microcapsules, which comprises the following technical steps: (1) dissolving enrofloxacin to alkali liquor and adding stearic acid in a molten state for a first envelop; (2) mixing with auxiliary materials for pelletizing and rounding, and adding a coating agent for a second layer of envelop in the course of rounding; and (3) baking semi-finished products to obtain finished products. The production method of the invention has the advantages that macromolecular substances are utilized to envelop the enrofloxacin to isolate the enrofloxacin from the external environment, thus not only covering the strong bitterness of the enrofloxacin, but also having no influence on feed palatability; and the enveloped enrofloxacin microcapsules are not dissolved in the acid environment and gradually dissolved in the alkaline environment of the intestinal tract so as to reach the purpose of slow release and prolong the action time of the enrofloxacin.

Description

A kind of production method of tasteless enteric 'Ennoxacin ' micro-capsule
Technical field
The present invention relates to feed and field of feed additive technology, relate in particular to the production method of tasteless enteric 'Ennoxacin ' micro-capsule.
Background technology
Enrofloxacin has another name called ethyl Ciprofloxacin, Enrofloxacin, and systematic naming method is 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1, and 4-dihydro-4-oxo-3-quinoline carboxylic acid is appointed as the animal specific medicine by country at present.Enrofloxacin is the broad-spectrum sterilization medicine, and mycoplasma is had special efficacy, and Escherichia coli, golden Portugal bacterium, streptococcus etc. are all had sterilization effectiveness.But Enrofloxacin has strong bitter taste, adds the feed intake that has a strong impact on pig in the feed to, causes this product to can not get using in the pig farm.
Summary of the invention
Above-mentioned defective at existing Enrofloxacin existence, applicant of the present invention has carried out improving research, a kind of production method of tasteless enteric 'Ennoxacin ' micro-capsule is provided, can cover the strong bitter taste of Enrofloxacin fully, and product is not dissolved in sour environment, in the enteron aisle alkaline environment, dissolve gradually, reach the purpose of slowly-releasing, prolong action time.
Originally it is as follows to put the technical scheme that invention adopts:
A kind of production method of tasteless enteric 'Ennoxacin ' micro-capsule, preparation process is as follows:
(1) ground floor bag quilt:
Take by weighing the recipe quantity Enrofloxacin, be dissolved in the sodium hydroxide solution of 1~1.2mol/l,, stir under the room temperature, make Enrofloxacin stearic acid mixture in 45~55 ℃ of stearic acid that add molten condition down;
(2) granulation and second layer bag quilt:
The Enrofloxacin stearic acid mixture adding starch that step (1) makes is granulated with round as a ball, in round as a ball process,, obtain the microcapsule granule of almost spherical at particle surface spraying acrylic resin;
(3) oven dry:
'Ennoxacin ' micro-capsule particle semi-finished product oven dry with step (2) makes obtains final finished;
The mass ratio of described each composition is an Enrofloxacin: sodium hydroxide solution: stearic acid: starch: acrylic resin=50~70: 4~6: 8~12: 10~25: 2~12.
Its further technical scheme is: the diameter of microcapsule granule is 50~400 μ m in the described step (2).
Useful technique effect of the present invention is:
The present invention wraps up dissolved state Enrofloxacin molecule earlier with the polymer substance stearic acid, again in the agent of Enrofloxacin particle surface spraying one deck enteric coating, Enrofloxacin and external environment is isolated in the round as a ball process of granulating.Behind bilayer bag quilt, can cover the strong bitter taste of Enrofloxacin fully, and because the characteristic of second layer enteric coating agent acrylic resin is not dissolved product in sour environment, dissolving gradually in the enteron aisle alkaline environment, reach the purpose of slowly-releasing, prolonged the action time of Enrofloxacin.
Description of drawings
Fig. 1 is a process chart of the present invention.
Fig. 2 is the absorption characteristic figure of different processing technology Enrofloxacins.
The specific embodiment
Below in conjunction with accompanying drawing, the specific embodiment of the present invention is described.
As shown in Figure 1, process of the present invention is divided following three steps:
One, Enrofloxacin ground floor bag quilt: take by weighing the former powder of recipe quantity Enrofloxacin earlier, be dissolved in 1~1.2mol/l sodium hydroxide solution, add the stearic acid (50 ℃) of molten condition, stir under the room temperature (temperature is reduced to normal temperature), make Enrofloxacin stearic acid mixture;
Two, Enrofloxacin stearic acid mixture is granulated and second layer bag quilt: above-mentioned mixture is added appropriate amount of auxiliary materials starch granulate with round as a ball, in round as a ball process, at particle surface spraying second layer enteric coating agent acrylic resin, obtain the microcapsule granule of almost spherical, the microcapsule granule diameter is 50~400 μ m.
Three, oven dry:, obtain final finished with the above-mentioned tasteless enteric 'Ennoxacin ' micro-capsule semi-finished product oven dry that obtains.
In order better to explain the present invention, the present invention will be further described below in conjunction with the specific embodiment.
Embodiment 1
Take by weighing the 50kg Enrofloxacin earlier, be dissolved in the sodium hydroxide solution that 4kg concentration is 1mol/l,, stir under the room temperature, make Enrofloxacin stearic acid mixture in 45 ℃ of stearic acid that add the 8kg molten condition down.Above-mentioned Enrofloxacin stearic acid mixture is added 25kg starch granulates with round as a ball as auxiliary material, in round as a ball process, at particle surface spraying 12kg second layer enteric coating agent acrylic resin, obtain the microcapsule granule of almost spherical, the microcapsule granule diameter is 50~400 μ m.Tasteless enteric 'Ennoxacin ' micro-capsule particle semi-finished product oven dry with obtaining obtains final finished.
Embodiment 2
Take by weighing the 60kg Enrofloxacin earlier, being dissolved in 5kg concentration is in the 1.1mol/l sodium hydroxide solution, in 50 ℃ of stearic acid that add the 10kg molten condition down, stirs under the room temperature, makes Enrofloxacin stearic acid mixture.Above-mentioned Enrofloxacin stearic acid mixture is added 10kg starch granulates with round as a ball as auxiliary material, in round as a ball process, at particle surface spraying 5kg second layer enteric coating agent acrylic resin, obtain the microcapsule granule of almost spherical, the microcapsule granule diameter is 50~400 μ m.Tasteless enteric 'Ennoxacin ' micro-capsule particle semi-finished product oven dry with obtaining obtains final finished.
Embodiment 3
Take by weighing the 70kg Enrofloxacin earlier, being dissolved in 6kg concentration is in the 1.2mol/l sodium hydroxide solution, in 55 ℃ of stearic acid that add the 12kg molten condition down, stirs under the room temperature, makes Enrofloxacin stearic acid mixture.Above-mentioned Enrofloxacin stearic acid mixture is added 10kg starch granulates with round as a ball as auxiliary material, in round as a ball process, at particle surface spraying 2kg second layer enteric coating agent acrylic resin, obtain the microcapsule granule of almost spherical, the microcapsule granule diameter is 50~400 μ m.Tasteless enteric 'Ennoxacin ' micro-capsule particle semi-finished product oven dry with obtaining obtains final finished.
Fig. 2 shows the absorption characteristic of different processing technology Enrofloxacins.As seen from Figure 2, under the situation of same medicine amount, adopt 'Ennoxacin ' micro-capsule that production method of the present invention makes and compare without the Enrofloxacin pulvis of parcel, concentration in pig blood and maximum RT all improve greatly, medicine uptake rate height, the slow releasing function effect is remarkable.
Above-described only is preferred implementation of the present invention, the invention is not restricted to above embodiment.Be appreciated that other improvement and variation that those skilled in the art directly derive or associate under the prerequisite that does not break away from spirit of the present invention and design, all should think to be included within protection scope of the present invention.

Claims (2)

1. the production method of a tasteless enteric 'Ennoxacin ' micro-capsule is characterized in that processing step is as follows:
(1) ground floor bag quilt:
Take by weighing the recipe quantity Enrofloxacin, be dissolved in the sodium hydroxide solution of 1~1.2mol/l,, stir under the room temperature, make Enrofloxacin stearic acid mixture in 45~55 ℃ of stearic acid that add molten condition down;
(2) granulation and second layer bag quilt:
The Enrofloxacin stearic acid mixture adding starch that step (1) makes is granulated with round as a ball, in round as a ball process,, obtain the microcapsule granule of almost spherical at particle surface spraying acrylic resin;
(3) oven dry:
'Ennoxacin ' micro-capsule particle semi-finished product oven dry with step (2) makes obtains final finished;
The mass ratio of described each composition is an Enrofloxacin: sodium hydroxide solution: stearic acid: starch: acrylic resin=50~70: 4~6: 8~12: 10~25: 2~12.
2. according to the production method of the described tasteless enteric 'Ennoxacin ' micro-capsule of claim 1, it is characterized in that the diameter of microcapsule granule in the described step (2) is 50~400 μ m.
CN2010105125310A 2010-10-20 2010-10-20 Production method for tasteless enteric enrofloxacin microcapsules Pending CN101965913A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105125310A CN101965913A (en) 2010-10-20 2010-10-20 Production method for tasteless enteric enrofloxacin microcapsules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105125310A CN101965913A (en) 2010-10-20 2010-10-20 Production method for tasteless enteric enrofloxacin microcapsules

Publications (1)

Publication Number Publication Date
CN101965913A true CN101965913A (en) 2011-02-09

Family

ID=43545196

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105125310A Pending CN101965913A (en) 2010-10-20 2010-10-20 Production method for tasteless enteric enrofloxacin microcapsules

Country Status (1)

Country Link
CN (1) CN101965913A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102302472A (en) * 2011-09-08 2012-01-04 河南迪冉生物科技有限公司 Enrofloxacin microcapsule and preparation method thereof
CN103070830A (en) * 2013-01-22 2013-05-01 无锡正大畜禽有限公司 Production method for 20-percent tilmicosin granules
CN103239422A (en) * 2012-04-26 2013-08-14 浙江康德权科技有限公司 Preparation method of smellless coated enrofloxacin preparation
CN105055374A (en) * 2015-09-16 2015-11-18 山西沃德华兽生物技术有限公司 Slow-release type sarafloxacin hydrochloride microcapsule and preparation method thereof
CN105078899A (en) * 2015-08-26 2015-11-25 四川农业大学 Enrofloxacin stratified high molecular taste mashing skeleton particle and preparation method thereof
CN107823186A (en) * 2017-11-20 2018-03-23 四川兴华药业有限责任公司 A kind of Enrofloxacin enteric powder formula and preparation method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1723902A (en) * 2005-06-10 2006-01-25 冯莉萍 'Ennoxacin' micro-capsule, and its prepn. method
CN101273980A (en) * 2007-06-08 2008-10-01 佛山市海纳川药业有限公司 Preparation of Enrofloxacin microcapsule and method of preparing the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1723902A (en) * 2005-06-10 2006-01-25 冯莉萍 'Ennoxacin' micro-capsule, and its prepn. method
CN101273980A (en) * 2007-06-08 2008-10-01 佛山市海纳川药业有限公司 Preparation of Enrofloxacin microcapsule and method of preparing the same

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102302472A (en) * 2011-09-08 2012-01-04 河南迪冉生物科技有限公司 Enrofloxacin microcapsule and preparation method thereof
CN102302472B (en) * 2011-09-08 2012-08-01 河南迪冉生物科技有限公司 Enrofloxacin microcapsule and preparation method thereof
CN103239422A (en) * 2012-04-26 2013-08-14 浙江康德权科技有限公司 Preparation method of smellless coated enrofloxacin preparation
CN103239422B (en) * 2012-04-26 2015-07-08 浙江康德权科技有限公司 Preparation method of smellless coated enrofloxacin preparation
CN103070830A (en) * 2013-01-22 2013-05-01 无锡正大畜禽有限公司 Production method for 20-percent tilmicosin granules
CN103070830B (en) * 2013-01-22 2014-08-13 无锡正大畜禽有限公司 Production method for 20-percent tilmicosin granules
CN105078899A (en) * 2015-08-26 2015-11-25 四川农业大学 Enrofloxacin stratified high molecular taste mashing skeleton particle and preparation method thereof
CN105078899B (en) * 2015-08-26 2018-06-29 四川农业大学 A kind of Enrofloxacin cladding macromolecule flavoring skeleton particle and preparation method thereof
CN105055374A (en) * 2015-09-16 2015-11-18 山西沃德华兽生物技术有限公司 Slow-release type sarafloxacin hydrochloride microcapsule and preparation method thereof
CN105055374B (en) * 2015-09-16 2017-11-03 山西沃德华兽生物技术有限公司 A kind of spacetabs type hydrochloric acid sarafloxacin microcapsules and preparation method thereof
CN107823186A (en) * 2017-11-20 2018-03-23 四川兴华药业有限责任公司 A kind of Enrofloxacin enteric powder formula and preparation method

Similar Documents

Publication Publication Date Title
CN101965913A (en) Production method for tasteless enteric enrofloxacin microcapsules
CN103830187B (en) A kind of tilmicosin solid dispersal granule and its preparation method and application
CN102985078B (en) For the microgranule of the oral delivery of animal
CN104856972A (en) Amoxicillin capsules and preparation method thereof
CN102688220B (en) Tilmicosin micro-capsule preparation and preparation method thereof
CN104397349A (en) Feeding intestinal tract sustained-release type compound acidifier and preparation method thereof
JP5802662B2 (en) Cashew nut shell oil with improved stability
CN103417512B (en) A kind of Biomox and preparation method thereof
CN104546907A (en) Enteric nano zinc oxide preparation and preparation method thereof
CN101611766B (en) Production method of enteric-coated kitasamycin for feed
CN104996737A (en) Feed acidifier coating preparation method
CN112244163A (en) Antibiotic-free piglet feed additive and preparation method and application method thereof
CN102058561A (en) Cefdinir capsule and preparation method thereof
CN103110596B (en) Cefprozil dispersible tablet and preparation method thereof
CN102805735A (en) Esomeprazole enteric pellet tablets and preparation method thereof
CN103006604B (en) Cefuroxime axetil tablets and preparation method thereof
CN102743369A (en) N-acetylcysteine pharmaceutical composition and preparation method thereof
CN105012246A (en) Nano-zinc oxide coating process
EP2320888B1 (en) Laidlomycin compositions and methods
JP6403242B2 (en) Monensin water dispersible granules by wet granulation method
CN106396633A (en) Clay ceramsite cat litter and preparation method thereof
CN103110588A (en) Production method of vitamin B6 granules
CN103006610B (en) Esomeprazole sodium enteric-coated tablet and preparation method thereof
CN102512414B (en) Sultamicittin composition and preparation method thereof
CN101999532A (en) Coating phosphoric acid for feeds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110209